Skip to content

A Comparison of the Performance of Standard Double Lumen Tubes With Vivasight DL™ Double Lumen Tubes for Lung Isolation in Patients Undergoing Thoracic Surgery

A Comparison of the Performance of Standard Double Lumen Tubes With Vivasight DL™ Double Lumen Tubes for Lung Isolation in Patients Undergoing Thoracic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01757977
Enrollment
25
Registered
2012-12-31
Start date
2012-08-31
Completion date
2013-01-31
Last updated
2013-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Performance and Safety of an Airway Management Device

Keywords

Vivasight DL, double lumen endotracheal tube, fiberoptic confirmation of tube position

Brief summary

The investigators have performed a number of studies on novel airway devices. In this randomized controlled trial he investigators would like to compare the performance of a new double-lumen endotracheal tube incorporating internal camera (Vivasight DL) with a standard double lumen tube.

Detailed description

Single lung ventilation is frequently carried out to facilitate surgery on the lungs and pleura. In most instances this is achieved by insertion of a double-lumen endotracheal tube and then selectively ventilating one lung or both. Precise positioning of these tubes is essential for optimal performance. It has become the standard of care to perform bronchoscopy to confirm tube position. A new double lumen endotracheal tube (Vivasight DL) has recently been developed. It has all the features of a standard double lumen endotracheal tube but also incorporates an internal camera which, when connected to an external screen, allows continuous confirmation of tube position. This is randomized, single blinded controlled trial. The participants will be allocated to two study groups (Vivasight DL or standard DLT), in which the primary airway management device will be respectively Vivasight DL double lumen tube or a standard double lumen endotracheal tube. Clinical Research Ethics Committee approval has been obtained. Suitable participants will be recruited after written informed consent. Standard anesthetic preassessment and anesthesia will be provided. Consenting patients passing the inclusion and exclusion criteria will be randomly allocated to either of the 2 study groups. Protocol for attempts at placement and tube position confirmation will be followed. The investigators will monitor a number of parameters, including time and ease of tube insertion, ability to verify tube position with the primary imaging modality for each group, need to perform tube position adjustment maneuvers, need to use fiberoptic bronchoscope during the case, quality of lung collapse, problems with ventilation and other. The primary hypothesis is that the new Vivasight DL tube system will provide a comparable optical view to the fiberoptic scope view obtained via standard double lumen endotracheal tube in order to confirm optimal position.

Interventions

DEVICEdouble lumen endotracheal tube placement and use

Sponsors

John Laffey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 16 - 85 yr old patients capable of informed consent * ASA (American Society of Anesthesiologists physical status) 1-3 * non-emergency surgery of expected duration \< 6 hours * one-lung ventilation required

Exclusion criteria

* BMI \> 35 * expected difficult airway * Mallampati score \>2 * increased risk of aspiration * upper airway or upper GI problems * live pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Adequacy of optical view obtained to confirm optimal tube position.within 60 minutes of commencement of general anesthesiaThe hypothesis is that the new Vivasight DL tube system will provide a comparable optical view to the fiberoptic scope view obtained via standard double lumen endotracheal tube in order to confirm optimal position.

Secondary

MeasureTime frameDescription
Operator rated Device Difficulty Scorewithin 60 minutes of commencement of general anesthesiaThe investigators will use 10cm visual analogue scale (VAS) to rate the overall ease of device use till successful placement achieved and position confirmed optically.
Time from initial laryngoscopy to passing tube through vocal cordsWithin 60 minutes of commencement of general anesthesia
Time to confirmation of tube positionwithin 60 minutes of commencement of general anesthesia
need to pass a fiberoptic bronchoscope during casewithin 15 hours of commencement of general anesthesia
presence of blood at the carina immediately post intubationwithin 60 minutes of commencement of general anesthesia
rate of malpositionwithin 15 hours of commencement of general anesthesiathe investigators will record the number/type of tube position adjustment maneuvers

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026